| LncRNA Information | ||||||
|---|---|---|---|---|---|---|
| ID | EL0523 | Name | GAPLINC | Aliases | LINC01540 | |
| Species | Homo sapiens | Chromosome | 18 | Start site | 3466250 | |
| End site | 3478978 | Chain | plus | Exon NO. | 3 | |
| Assembly | Ensembl Release 89 | Class | lincRNA | NCBI accession | NR_110429, NR_110428 | |
| Ensembl | ENSG00000266835 | Sequence | ||||
| Disease | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Disease | Method | Sample | Expression pattern | Dysfunction type | Description | PMID | Source | ||
| gastric cancer | microarray, ISH etc. | gastric cancer tissue | up-regulated | N/A | GAPLINC is a 924-bp-long lncRNA that is highly expressed in gastric cancer tissues. GAPLINC suppression and with gene expression profiling in gastric cancer cells revealed alterations in cell migration pathways, with CD44 expression the most highly correlated. Manipulating GAPLINC | 25277524 | LncRNADisease Lnc2Cancer | ||